Professur für Molekulare Mechanismen der Organfibrose

Long term outcomes of immunomodulatory drugs in SSc-ILD - data from the German SSc-network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis (2019) Codullo V, Cova E, Pandolfi L, Breda S, Morosini M, Frangipane V, Malatesta M, et al. Journal article Type 3 Innate Lymphoid Cells in models of psoriasis and psoriatic arthritis (2019) Raimondo MG, Rauber S, Distler J, Schett G, Ramming A Conference contribution Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis (2019) Becker M, Graf N, Sauter R, Allanore Y, Curram J, Denton CP, Khanna D, et al. Journal article Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases (2019) Wollin L, Distler J, Redente EF, Riches DW, Stowasser S, Schlenker-Herceg R, Maher TM, Kolb M Journal article, Review article Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis (2019) Sobanski V, Giovannelli J, Allanore Y, Riemekasten G, Airo P, Vettori S, Cozzi F, et al. Journal article RELATIONSHIP BETWEEN ANTI-MDA5 ANTIBODIES AND CANCER: RETROSPECTIVE ANALYSIS OF AN INTERNATIONAL AND MULTIDISCIPLINARY COHORT (2019) De Stefano L, Castaneda S, De Langhe E, Distler J, Knitza J, Cavazzana I, Meyer A, et al. Conference contribution POTENTIAL CELLULAR AND MOLECULAR TARGETS (2019) Distler J Conference contribution PU.1 INHIBITOR DB1976 CONTROLS FIBROBLAST POLARIZATION IN SYSTEMIC SCLEROSISAND LEADS TO REGRESSION OF FIBROSIS IN DIFFERENT MODELS OF ORGAN FIBROSIS (2019) Wohlfahrt T, Rauber S, Luber M, Soare A, Weber S, Matei AE, Chen CW, et al. Conference contribution FOSL-2 IS A REPRESSOR OF FOXP3 EXPRESSION DURING TREG DEVELOPMENT AND CONTROLS AUTOIMMUNITY (2019) Renoux F, Stellato M, Vogetseder A, Huang R, Subramaniam A, Blyszczuk P, Distler J, et al. Conference contribution